- Published at
- by gurufocus.com
negative
negative
BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation Immuno-Oncology Priority Programs at AACR 2025 | BNTX Stock News
BioNTech (BNTX) showcases its oncology pipeline including mRNA therapies at the AACR Annual Meeting 2025 in Chicago. BNT327 and BNT116 demonstrate signi